Tumor markers in prostate cancer I: Blood-based markers

Pre-analytical in-vitro stability of [-2]proPSA in blood and serum

(2010) Axel Semjonow et al.   CLINICAL BIOCHEMISTRY

A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

(2010) A. J. Vickers et al.   CLINICAL CANCER RESEARCH

Reducing Unnecessary Biopsy During Prostate Cancer Screening Using a Four-Kallikrein Panel: An Independent Replication

(2010) Andrew Vickers et al.   JOURNAL OF CLINICAL ONCOLOGY

1986 AN EMPIRICAL EVALUATION OF THE NATIONAL CANCER CENTER NETWORK GUIDELINES ON PROSTATE SPECIFIC ANTIGEN VELOCITY IN PROSTATE CANCER DETECTION

(2010) Andrew Vickers et al.   JOURNAL OF UROLOGY

Cancer Statistics, 2009

(2009) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Pro-Prostate-Specific Antigen Measurements in Serum and Tissue Are Associated with Treatment Necessity among Men Enrolled in Expectant Management for Prostate Cancer

(2009) D. V. Makarov et al.   CLINICAL CANCER RESEARCH

Pretreatment Prostate-Specific Antigen (PSA) Velocity and Doubling Time Are Associated With Outcome but Neither Improves Prediction of Outcome Beyond Pretreatment PSA Alone in Patients Treated With Radical Prostatectomy

(2009) Matthew Frank O'Brien et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate Cancer–Specific Mortality After Radical Prostatectomy for Patients Treated in the Prostate-Specific Antigen Era

(2009) Andrew J. Stephenson et al.   JOURNAL OF CLINICAL ONCOLOGY

Yearly Prostate Specific Antigen and Digital Rectal Examination Fluctuations in a Screened Population

(2009) Donna Pauler Ankerst et al.   JOURNAL OF UROLOGY

Screening and Prostate-Cancer Mortality in a Randomized European Study

(2009) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence

(2009) Robert S. Svatek et al.   PROSTATE

Benign Prostatic Hyperplasia-associated Free Prostate-specific Antigen Improves Detection of Prostate Cancer in an Artificial Neural Network

(2009) Carsten Stephan et al.   UROLOGY

Intermethod Differences in Results for Total PSA, Free PSA, and Percentage of Free PSA

(2008) Patricia R. Slev et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Decision Analysis for the Evaluation of Diagnostic Tests, Prediction Models, and Molecular Markers

(2008) Andrew J Vickers   AMERICAN STATISTICIAN

Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers

(2008) Andrew J Vickers et al.   BMC Medical Informatics and Decision Making

Prostate-specific antigen at or before age 50 as a predictor of advanced prostate cancer diagnosed up to 25 years later: A case-control study

(2008) David Ulmert et al.   BMC Medicine

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

(2008) Andrew J Vickers et al.   BMC Medicine

Systematic review of statistical methods used in molecular marker studies in cancer

(2008) Andrew J. Vickers et al.   CANCER

Assessing outcomes in prostate cancer clinical trials

(2008) Gretchen A. Gignac et al.   CANCER

An updated catalog of prostate cancer predictive tools

(2008) Shahrokh F. Shariat et al.   CANCER

Preoperative Plasma Endoglin Levels Predict Biochemical Progression After Radical Prostatectomy

(2008) R. S. Svatek et al.   CLINICAL CANCER RESEARCH

Improved Prediction of Disease Relapse after Radical Prostatectomy through a Panel of Preoperative Blood-Based Biomarkers

(2008) S. F. Shariat et al.   CLINICAL CANCER RESEARCH

Use of Preoperative Plasma Endoglin for Prediction of Lymph Node Metastasis in Patients with Clinically Localized Prostate Cancer

(2008) J. A. Karam et al.   CLINICAL CANCER RESEARCH

Inventory of prostate cancer predictive tools

(2008) Shahrokh F Shariat et al.   CURRENT OPINION IN UROLOGY

Perspectives on Prostate Cancer Biomarkers

(2008) Shahrokh F. Shariat et al.   EUROPEAN UROLOGY

Predictive Value of the Differential Expression of the Urokinase Plasminogen Activation Axis in Radical Prostatectomy Patients

(2008) Amit Gupta et al.   EUROPEAN UROLOGY

Endoglin (CD105) as a urinary and serum marker of prostate cancer

(2008) Kazutoshi Fujita et al.   INTERNATIONAL JOURNAL OF CANCER

Long-Term Prediction of Prostate Cancer: Prostate-Specific Antigen (PSA) Velocity Is Predictive but Does Not Improve the Predictive Accuracy of a Single PSA Measurement 15 Years or More Before Cancer Diagnosis in a Large, Representative, Unscreened Population

(2008) David Ulmert et al.   JOURNAL OF CLINICAL ONCOLOGY

External Validation of a Biomarker-Based Preoperative Nomogram Predicts Biochemical Recurrence After Radical Prostatectomy

(2008) Shahrokh F. Shariat et al.   JOURNAL OF CLINICAL ONCOLOGY

A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases

(2008) Carsten Stephan et al.   PROSTATE

New blood-based biomarkers for the diagnosis, staging and prognosis of prostate cancer

(2007) Shahrokh F. Shariat et al.   BJU INTERNATIONAL

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

(2007) Shahrokh F. Shariat et al.   CANCER

Early Detection of Prostate Cancer in 2007

(2007) Fritz H. Schröder et al.   EUROPEAN UROLOGY